Madrigal Pharmaceuticals
Overview
We are a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis ( MASH ), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. MASH was previously known as nonalcoholic steatohepatitis ( NASH ). MASH is the leading cause of liver transplantation in women, the second leading cause of all liver transplantation in the United States and the fastest-growing indication for liver transplantation in Europe.
Divisions & what they sell
A rep inherits the attributes of their division, not the company — “worked at Madrigal Pharmaceuticals” means something different in each of these.
Madrigal Pharmaceuticals
Verified · company site (no SEC)- Call point
- endocrinologist
- Sales motion
- detailing
- Reimbursement
- pharmacy benefit (retail)
Products
Competes with
Where a rep in this division can realistically move.